Gaudium IVF IPO subscribed 2.53 times so far on Day 2: 10 key things retail investors should know

Gaudium IVF and Women Health IPO: The initial public offering (IPO) of fertility services provider Gaudium IVF and Women Health Ltd has been subscribed 2.53 times so far on the second day of share sale on Monday, February 23.

The company's IPO received bids for 3,69,28,143 shares against 1,46,20,340 shares on offer, according to the NSE data until 3:00 pm.

The quota for retail individual investors (RIIs) was subscribed 3.50 times, while the portion for non-institutional investors (NIIs) received 3.59 times subscription. The qualified institutional buyers (QIBs) part was booked 2%.

Gaudium IVF and Women Health IPO: Key things to know

• Gaudium IVF and Women Health IPO subscription period: The initial public offering is live from February 20 to February 24.
• IPO offer structure: The ₹165 crore book-build issue is a mix of fresh issuance of shares valued at ₹90 crore and an offer for sale (OFS) component of ₹75 crore.
• Gaudium IVF and Women Health IPO price band: The price range has been set at ₹75 to ₹79 per share.
• Gaudium IVF IPO anchor investors: Before the IPO, the company raised ₹49.5 crore in the anchor round from investors, including MERU Investment Fund PCC-CELL, Carnelian India Multi Strategy Fund, Hornbill Orchid India Fund and Sanshi Fund I.
• Gaudium IVF and Women Health IPO lot size: An application consists of 189 shares and in multiples thereafter.
• Reservation: The company has reserved half of the issue for qualified institutional buyers, 15% for non-institutional investors and 35% for retail individual investors.
• Objectives: Under the OFS, Dr Manika Khanna will divest their stake. The fresh issue proceeds will be utilised for funding capital expenditure towards setting up new IVF centres, debt repayment and general corporate purposes.
• Book-running lead manager and registrar: Sarthi Capital Advisors is the book-running lead manager for the issue, while Bigshare Services is the registrar.
• Gaudium IVF and Women IPO allotment date: The basis of allotment is likely to be finalised on February 25.
• Listing date: The listing on the NSE and the BSE will take place on February 27.

Gaudium IVF and Women Health IPO GMP

According to investorgain.com and media reports, unlisted shares of Gaudium IVF and Women Health are trading at ₹87.5, reflecting a grey market premium (GMP) of 10.76% over the upper price band of ₹79.